Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

by Reham Abdel-Wahab, Gauri R. Varadhachary, Priya R. Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle
Published 2018-05-01

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery

by Marc Uemura, Wei Qiao, Keith Fournier, Jeffrey Morris, Paul Mansfield, Cathy Eng, Richard E Royal, Robert A Wolff, Kanwal Raghav, Gary N Mann, Michael J Overman
Published 2017-05-01

Natural history and prognostic factors for localised small bowel adenocarcinoma

by Jane Thomas, Andreina Colina, Hyunsoo Hwang, Huamin Wang, Matthew H G Katz, Ryan Sun, Jeffrey E Lee, Ching-Wei Tzeng, Robert A Wolff, Kanwal Raghav, Michael J Overman
Published 2020-12-01

PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer

by Julia E. Douglas, Suyu Liu, Junsheng Ma, Robert A. Wolff, Shubham Pant, Anirban Maitra, Eric P. Tamm, Priya Bhosale, Matthew H. G. Katz, Gauri R. Varadhachary, Eugene J. Koay
Published 2022-01-01

584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

by Aung Naing, Funda Meric-Bernstam, Shubham Pant, Milind Javle, Juhee Song, Anas Alshawa, Bettzy Stephen, Abdulrazzak Zarifa, Jordi Rodon, Yali Yang, Robert A Wolff, Anne Knisely, Van Morris, Jibran Ahmed
Published 2023-11-01

Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma.

by Qingqing Liu, John Stewart, Hua Wang, Asif Rashid, Jun Zhao, Matthew H Katz, Jeffrey E Lee, Jason B Fleming, Anirban Maitra, Robert A Wolff, Gauri R Varadhachary, Sunil Krishnan, Huamin Wang
Published 2017-01-01

Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.

by Oliver H Wang, Nancy Azizian, Ming Guo, Michela Capello, Defeng Deng, Fenglin Zang, Jason Fry, Matthew H Katz, Jason B Fleming, Jeffrey E Lee, Robert A Wolff, Samir Hanash, Huamin Wang, Anirban Maitra
Published 2016-01-01

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and...

by Tom Z. Liang, Matthew H. G. Katz, Laura R. Prakash, Deyali Chatterjee, Hua Wang, Michael Kim, Ching-Wei D. Tzeng, Naruhiko Ikoma, Robert A. Wolff, Dan Zhao, Eugene J. Koay, Anirban Maitra, Suprateek Kundu, Huamin Wang
Published 2023-06-01

Clinical utility of circulating cell-free DNA in advanced colorectal cancer.

by Allan A Lima Pereira, Maria Pia Morelli, Michael Overman, Bryan Kee, David Fogelman, Eduardo Vilar, Imad Shureiqi, Kanwal Raghav, Cathy Eng, Shanequa Manuel, Shadarra Crosby, Robert A Wolff, Kimberly Banks, Richard Lanman, AmirAli Talasaz, Scott Kopetz, Van Morris
Published 2017-01-01

Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.

by Chaitanya R Churi, Rachna Shroff, Ying Wang, Asif Rashid, HyunSeon C Kang, Jacqueline Weatherly, Mingxin Zuo, Ralph Zinner, David Hong, Funda Meric-Bernstam, Filip Janku, Christopher H Crane, Lopa Mishra, Jean-Nicholas Vauthey, Robert A Wolff, Gordon Mills, Milind Javle
Published 2014-01-01

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy

by Yi Tat Tong, Zongshan Lai, Matthew H. G. Katz, Laura R Prakash, Hua Wang, Deyali Chatterjee, Michael Kim, Ching-Wei D. Tzeng, Jeffrey E. Lee, Naruhiko Ikoma, Asif Rashid, Robert A. Wolff, Dan Zhao, Eugene J. Koay, Anirban Maitra, Huamin Wang
Published 2023-05-01

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma

by Ahmed O. Kaseb, Abedul Haque, Deeksha Vishwamitra, Manal M. Hassan, Lianchun Xiao, Bhawana George, Vishal Sahu, Yehia I. Mohamed, Roberto Carmagnani Pestana, Jamie Lynne Lombardo, Rony Avritscher, James C. Yao, Robert A. Wolff, Asif Rashid, Jeffrey S. Morris, Hesham M. Amin, Hesham M. Amin
Published 2022-10-01

Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study

by Mohamed Zaid, Lauren Widmann, Annie Dai, Kevin Sun, Jie Zhang, Jun Zhao, Mark W. Hurd, Gauri R. Varadhachary, Robert A. Wolff, Anirban Maitra, Matthew H. G. Katz, Joseph M. Herman, Huamin Wang, Michael V. Knopp, Terence M. Williams, Priya Bhosale, Eric P. Tamm, Eugene J. Koay
Published 2020-12-01

Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.

by Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, Ganiraju Manyam, Bryan K Kee, David R Fogelman, Arvind Dasari, Kanwal Raghav, Eduardo Vilar, Shanequa Manuel, Imad Shureiqi, Robert A Wolff, Keyur P Patel, Raja Luthra, Kenna Shaw, Cathy Eng, Dipen M Maru, Mark J Routbort, Funda Meric-Bernstam, Scott Kopetz
Published 2017-01-01

Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients

by Chirayu Mohindroo, Merve Hasanov, Jane E. Rogers, Wenli Dong, Laura R. Prakash, Seyda Baydogan, Jonathan D. Mizrahi, Michael J. Overman, Gauri R. Varadhachary, Robert A. Wolff, Milind M. Javle, David R. Fogelman, Michael T. Lotze, Michael P. Kim, Matthew H.G. Katz, Shubham Pant, Ching‐Wei D. Tzeng, Florencia McAllister
Published 2021-08-01

765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of t...

by Robert H Vonderheide, Andrew H Ko, Danny Khalil, Oliver Rosen, Robert A Wolff, James Francis, Samantha Bucktrout, Christopher R Cabanski, Silvia Boffo, Zev A Wainberg, Samik Upadhaya, Eileen M O’Reilly, Mark H O’Hara, George Fisher, Jamie Arnott, Ana Rosa Saez-Ibanez, Jay Campbell, Ute Dugan, Jill O’Donnell-Tormey
Published 2023-11-01

Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer.

by Awalpreet S Chadha, Heath D Skinner, Jillian R Gunther, Mark F Munsell, Prajnan Das, Bruce D Minsky, Marc E Delclos, Deyali Chatterjee, Huamin Wang, Marilyn Clemons, Geena George, Pankaj K Singh, Matthew H Katz, Jason B Fleming, Milind M Javle, Robert A Wolff, Gauri R Varadhachary, Christopher H Crane, Sunil Krishnan
Published 2016-01-01

Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

by Chantale Bernatchez, Shubham Pant, Rodabe Amaria, Marie-Andree Forget, Milind Javle, Donastas Sakellariou-Thompson, Karen H Lu, Scott Kopetz, Mara B Antonoff, Cara L Haymaker, Ying Yuan, Robert A Wolff, Michael J Overman, Anne Knisely, Amir A Jazaeri, Bryan Fellman, Kelly Rangel, David Vining, Ching-Wei D Tzeng, Kathryn Lito
Published 2024-02-01

Survival improvement for patients with metastatic colorectal cancer over twenty years

by Fadl A. Zeineddine, Mohammad A. Zeineddine, Abdelrahman Yousef, Yue Gu, Saikat Chowdhury, Arvind Dasari, Ryan W. Huey, Benny Johnson, Bryan Kee, Michael S. Lee, Maria Pia Morelli, Van K. Morris, Michael J. Overman, Christine Parseghian, Kanwal Raghav, Jason Willis, Robert A. Wolff, Yoshikuni Kawaguchi, Jean-Nicolas Vauthey, Ryan Sun, Scott Kopetz, John Paul Shen
Published 2023-02-01

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience

by Alexander F. Bagley, Ethan B. Ludmir, Anirban Maitra, Bruce D. Minsky, Grace Li Smith, Prajnan Das, Albert C. Koong, Emma B. Holliday, Cullen M. Taniguchi, Matthew H.G. Katz, Eric P. Tamm, Robert A. Wolff, Michael J. Overman, Shivani Patel, Michael P. Kim, Ching-Wei D. Tzeng, Naruhiko Ikoma, Manoop S. Bhutani, Eugene J. Koay
Published 2022-03-01